Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stoke Therapeutics, Inc.

10.88
-0.0600-0.55%
Volume:372.31K
Turnover:4.04M
Market Cap:594.01M
PE:12.41
High:11.00
Open:10.89
Low:10.64
Close:10.94
Loading ...
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 18, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]